A population-based study on treatment and outcomes in patients with gastric adenocarcinoma diagnosed with distant interval metastases

被引：5
作者：
Dijksterhuis, Willemieke P. M. [1 ,2 ]
Kroese, Tiuri E. [3 ,4 ]
Verhoeven, Rob H. A. [1 ,2 ]
Van Rossum, Peter S. N. [4 ]
Mook, Stella [4 ]
Mohammad, Nadia Haj [5 ]
Hulshof, Maarten C. C. M. [6 ]
Gisbertz, Suzanne S. [7 ]
Ruurda, Jelle P. [3 ]
van Oijen, Martijn G. H. [1 ,2 ]
van Hillegersberg, Richard [3 ]
van Laarhoven, Hanneke W. M. [1 ]
机构：
[1] Univ Amsterdam, Amsterdam UMC, Dept Med Oncol, Canc Ctr Amsterdam, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[2] Netherlands Comprehens Canc Org IKNL, Dept Res & Dev, POB 19079, NL-3501 DB Utrecht, Netherlands
[3] Univ Utrecht, Univ Med Ctr Utrecht, Dept Surg, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands
[4] Univ Utrecht, Univ Med Ctr Utrecht, Dept Radiat Oncol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands
[5] Univ Utrecht, Univ Med Ctr Utrecht, Dept Med Oncol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands
[6] Univ Amsterdam, Amsterdam UMC, Dept Radiat Oncol, Canc Ctr Amsterdam, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[7] Univ Amsterdam, Amsterdam UMC, Dept Surg, Canc Ctr Amsterdam, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
来源：
EJSO | 2022年 / 48卷 / 09期
关键词：
Gastric neoplasms; Drug therapy; Neoadjuvant therapy; Neoplasm metastases; CANCER; RECURRENCE; PATTERNS;
D O I：
10.1016/j.ejso.2022.03.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: In patients with gastric or gastroesophageal junction (GEJ) cancer treated with curative intent, distant interval metastases may be detected after start of neoadjuvant chemotherapy or during surgery. The aim of this study was to explore characteristics, allocated treatment and overall survival (OS) in gastric/GEJ cancer patients with interval metastases, and to compare OS with synchronous metastatic gastric/GEJ cancer patients who started palliative chemotherapy. Methods: Patients with interval metastases were selected from the Netherlands Cancer Registry by including patients with potentially curable gastric/GEJ adenocarcinoma (2010e2018) who started chemotherapy without concurrent radiotherapy. The OS since start of neoadjuvant treatment of patients with interval metastases was compared with a propensity score-matched cohort of patients with synchronous metastases who received palliative systemic treatment. Results: 164 patients with interval metastases diagnosed in 2010e2018 were included. Metastases were most frequently detected during surgery (83%) and most frequently located in the peritoneum (77%). Peritoneal interval metastases were observed in 63% and 80% of the patients who did and did not have a diagnostic laparoscopy prior to neoadjuvant treatment, respectively (P = 0.041). Median OS was 8.9 months (IQR 5.5-13.4), compared to 8.0 months (IQR 4.1-14.1) in matched synchronous metastatic patients calculated from start of neoadjuvant and palliative systemic treatment, respectively (P = 0.848). Conclusion: This population-based study shows that gastric/GEJ cancer patients who started neoadjuvant treatment and were diagnosed with interval metastases most frequently suffered from peritoneal metastases detected during (exploratory) surgery, even when a diagnostic laparoscopy was performed before start of treatment. OS was comparable to patients with synchronous metastatic gastric/GEJ cancer. (c) 2022 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码：1964 / 1971
页数：8
相关论文
共 29 条
[11]   Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study [J].
Dijksterhuis, Willemieke P. M. ;
Verhoeven, Rob H. A. ;
Meijer, Sybren L. ;
Slingerland, Marije ;
Mohammad, Nadia Haj ;
de Vos-Geelen, Judith ;
Beerepoot, Laurens, V ;
van Voorthuizen, Theo ;
Creemers, Geert-Jan ;
van Oijen, Martijn G. H. ;
van Laarhoven, Hanneke W. M. .
GASTRIC CANCER, 2020, 23 (04) :579-590
[12]   Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence study [J].
Dijksterhuis, Willemieke P. M. ;
Verhoeven, Rob H. A. ;
Slingerland, Marije ;
Mohammad, Nadia Haj ;
de Vos-Geelen, Judith ;
Beerepoot, Laurens, V ;
van Voorthuizen, Theo ;
Creemers, Geert-Jan ;
van Oijen, Martijn G. H. ;
van Laarhoven, Hanneke W. M. .
INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (07) :1889-1901
[13]  
Fritz A, 2013, INT CLASSIFICATION D, V3rd, DOI [10.1016/j.matpr.2017.01.181, DOI 10.1016/J.MATPR.2017.01.181]
[14]   Refraining from resection in patients with potentially curable gastric carcinoma [J].
Gertsen, Emma C. ;
Brenkman, Hylke J. F. ;
Brosens, L. A. A. ;
Luijten, Josianne C. H. B. M. ;
Mohammad, Nadia Haj ;
Verhoeven, Rob H. A. ;
van Hillegersberg, Richard ;
Ruurda, Jelle P. .
EJSO, 2021, 47 (05) :1062-1068
[15]   Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials [J].
Glatz, Torben ;
Verst, Rasmus ;
Kuvendjiska, Jasmina ;
Bronsert, Peter ;
Becker, Heiko ;
Hoeppner, Jens ;
Kulemann, Birte .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) :1-14
[16]   Staging laparoscopy improves treatment decision-making for advanced gastric cancer [J].
Hu, Yan-Feng ;
Deng, Zhen-Wei ;
Liu, Hao ;
Mou, Ting-Yu ;
Chen, Tao ;
Lu, Xin ;
Wang, Da ;
Yu, Jiang ;
Li, Guo-Xin .
WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (05) :1859-1868
[17]   Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II) [J].
Koemans, W. J. ;
van der Kaaij, R. T. ;
Boot, H. ;
Buffart, T. ;
Veenhof, A. A. F. A. ;
Hartemink, K. J. ;
Grootscholten, C. ;
Snaebjornsson, P. ;
Retel, V. P. ;
van Tinteren, H. ;
Vanhoutvin, S. ;
van der Noort, V. ;
Houwink, A. ;
Hahn, C. ;
Huitema, A. D. R. ;
Lahaye, M. ;
Los, M. ;
van den Barselaar, P. ;
Imhof, O. ;
Aalbers, A. ;
van Dam, G. M. ;
van Etten, B. ;
Wijnhoven, B. P. L. ;
Luyer, M. D. P. ;
Boerma, D. ;
van Sandick, J. W. .
BMC CANCER, 2019, 19 (1)
[18]   Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort [J].
Koemans, Willem J. ;
Lurvink, Robin J. ;
Grootscholten, Cecile ;
Verhoeven, Rob H. A. ;
de Hingh, Ignace H. ;
van Sandick, Johanna W. .
GASTRIC CANCER, 2021, 24 (04) :800-809
[19]   Recurrence after preoperative chemotherapy and surgery for gastric adenocarcinoma: a multicenter study [J].
Mokadem, I. ;
Dijksterhuis, W. P. M. ;
van Putten, M. ;
Heuthorst, L. ;
de Vos-Geelen, J. M. ;
Mohammad, N. Haj ;
Nieuwenhuijzen, G. A. P. ;
van Laarhoven, H. W. M. ;
Verhoeven, R. H. A. .
GASTRIC CANCER, 2019, 22 (06) :1263-1273
[20]   The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer [J].
Nakanishi, Koki ;
Kanda, Mitsuro ;
Umeda, Shinichi ;
Tanaka, Chie ;
Kobayashi, Daisuke ;
Hayashi, Masamichi ;
Yamada, Suguru ;
Kodera, Yasuhiro .
GASTRIC CANCER, 2019, 22 (06) :1143-1152
123